The Femtosecond Laser in Residency Training (FLIRT) Pilot Study

NCT ID: NCT03115216

Last Updated: 2019-09-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2017-07-31

Study Completion Date

2018-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This pilot study aims to primarily assess the rate of complication of anterior vitrectomy for patients undergoing femtosecond laser-assisted (FLA) cataract extraction and intraocular lens placement (CEIOL) compared to manual CEIOL, when performed by resident physicians under direct attending supervision. In this pilot study, the investigators aim to assess what the incidence of anterior vitrectomy is for each group, in order to better understand the sample size needed to assess whether there is a difference between these two groups. Secondarily, it will gather preliminary data on safety and refractive outcomes for patients undergoing these interventions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cataract Intraocular Lens Implantation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

FLA-CEIOL

Femtosecond laser assisted cataract extraction and intraocular lens placement

Group Type ACTIVE_COMPARATOR

FLA-CEIOL

Intervention Type PROCEDURE

Femtosecond laser-assisted cataract extraction and intraocular lens placement

CEIOL

Clear corneal incision with manual cataract extraction and intraocular lens placement

Group Type ACTIVE_COMPARATOR

CEIOL

Intervention Type PROCEDURE

Manual cataract extraction and intraocular lens placement

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

FLA-CEIOL

Femtosecond laser-assisted cataract extraction and intraocular lens placement

Intervention Type PROCEDURE

CEIOL

Manual cataract extraction and intraocular lens placement

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients of the Los Angeles County + University of Southern California Medical Center (LAC+USC) who are 40 years or older with visually significant cataracts asking for surgical intervention.
* Cataract must be visually and clinically significant on examination as determined by the resident surgeon and the attending physician.

Exclusion Criteria

* Age less than 40
* Visual acuity 20/30 or better with refraction in the study eye
* Any previous ocular surgery
* Patient request for monovision or for correction at near at the expense of distance
* Patient and physician decision to use an IOL implant other than monofocal IOL
* Corneal pathology (e.g. Fuch's dystrophy, corneal opacity or scar, corneal ectasia)
* Posterior or anterior capsular plaque
* Posterior polar cataract
* White cataract
* Subluxated lens, weak zonules, or phacodonesis
* Pseudoexfoliation syndrome
* Failure of preoperative pupillary dilatation (\< 6 mm dilation)
* History of uveitis
* History of retinal detachment
* Untreated or active proliferative diabetic retinopathy
* Untreated or active diabetic macular edema
* Ocular diseases that may affect visual acuity or the operation (including and not limited to macular degeneration, retinitis pigmentosa, macular hole, advanced or end-stage glaucoma)
* Neurological or systemic diseases that may affect visual acuity or the safety of the operation
Minimum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Alcon Research

INDUSTRY

Sponsor Role collaborator

University of Southern California

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FLIRT

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.